Remove 2007 Remove Cell Based Assays Remove Compound Screening
article thumbnail

Re-assessing the risks of drug-induced arrhythmias during drug discovery

Drug Discovery World

However, many other drugs exhibit a more complex multichannel pharmacology 7 , which is much harder to interpret and cannot be easily modelled by screening against a single ion channel. Scannell et al. 2022) Nature Reviews Drug Discovery, 21: 915–931. Treherne (2006). Current Pharmaceutical Design, 12(4): 397- 406 Rassmussen et al.

Drugs 130